NEWS CENTER

Home page

2024

Paclitaxel Product Introduction

Paclitaxel, a natural substance derived from the yew tree, has anti-tumor activity. The main mechanism is to prevent the proliferation of tumor cells by interfering with the polymerization of tubulin, so as to achieve the anti-cancer effect. At present, paclitaxel is widely used in the treatment of breast cancer, ovarian cancer, lung cancer and other cancers.
In clinical applications, paclitaxel is usually administered by intravenous injection. Dosage will be based on the patient's physical condition and the severity of the condition and should be adjusted by an experienced doctor. In the course of medication, patients need to closely monitor blood routine, liver and kidney function and other indicators, as well as whether there are pain or swelling and other adverse reactions at the injection site.
In addition, for pregnant women, lactating women and patients with severe liver and kidney dysfunction, paclitaxel should be used with caution. At the same time, because paclitaxel may cause some adverse reactions, such as bone marrow suppression, infection, etc., patients need to be checked regularly during medication to detect and deal with adverse reactions in time.
In summary, paclitaxel, as an important anticancer drug, plays an irreplaceable role in the treatment of malignant tumors. Clinicians should choose paclitaxel reasonably according to the specific conditions of patients, and pay close attention to the body reaction of patients in the process of medication, so as to ensure the treatment effect and minimize the occurrence of adverse reactions.